The Value of the Serum Neurofilament Protein Heavy Chain as a Biomarker for Peri-operative Brain Injury after Carotid Endarterectomy

Neurochemical Research

Volumn 34, Issue 11, 2009, Pages 1969-1974

  Sellner, Johann ^a   Petzold, Axel ^b   Sadikovic, Suwad ^a   Esposito, Lorena ^a   Weber, Martin S ^a   Heider, Peter ^a   Eckstein, Hans Henning ^a   Hemmer, Bernhard ^a   Poppert, Holger ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Biomarker; Brain injury; Carotid endarterectomy; Neurofilaments; Stroke

Indexed keywords

BIOLOGICAL MARKER; NEUROFILAMENT PROTEIN;

ADULT; AGED; ARTICLE; BRAIN INJURY; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAVY CHAIN; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROFILAMENT PROTEINS; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 70349589702     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-9976-x     Document Type: Article

References (22)

1. VL Feigin CM Lawes DA Bennett, et al. 2003 Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century Lancet Neurol 2 43 53 10.1016/S1474-4422(03)00266-7 12849300 10.1016/S1474-4422(03)00266-7 (Pubitemid 37443343)
2. A Halliday A Mansfield J Marro, et al. 2004 Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial Lancet 363 1491 1502 10.1016/S0140-6736(04)16146-1 15135594 10.1016/S0140-6736(04)16146-1 1:STN:280:DC%2BD2c3jvVygug%3D%3D (Pubitemid 38596824)
3. ECST Trial 1998 Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) Lancet 351 1379 1387 10.1016/S0140-6736(97)09292-1 10.1016/S0140-6736(97)09292-1 (Pubitemid 28209995)
4. S Schnaudigel K Groschel SM Pilgram, et al. 2008 New brain lesions after carotid stenting versus carotid endarterectomy: a systematic review of the literature Stroke 39 1911 1919 10.1161/STROKEAHA.107.500603 18388346 10.1161/STROKEAHA.107.500603
5. A Petzold K Rejdak A Belli, et al. 2005 Axonal pathology in subarachnoid and intracerebral hemorrhage J Neurotrauma 22 407 414 10.1089/neu.2005.22.407 15785235 10.1089/neu.2005.22.407 1:STN:280:DC%2BD2M7lt1Whug%3D%3D (Pubitemid 40434688)
6. J Guy G Shaw FN Ross-Cisneros, et al. 2008 Phosphorylated neurofilament heavy chain is a marker of neurodegeneration in Leber hereditary optic neuropathy (LHON) Mol Vis 14 2443 2450 19104679 1:CAS:528:DC%2BD1MXnslKhug%3D%3D
7. A Petzold K Rejdak GT Plant 2004 Axonal degeneration and inflammation in acute optic neuritis J Neurol Neurosurg Psychiatry 75 1178 1180 10.1136/jnnp.2003.017236 15258226 10.1136/jnnp.2003.017236 1:STN:280: DC%2BD2czlsFGhtw%3D%3D (Pubitemid 39005781)
8. S Chaturvedi A Bruno T Feasby, et al. 2005 Carotid endarterectomy-an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology 65 794 801 10.1212/01.wnl.0000176036.07558.82 16186516 10.1212/01.wnl.0000176036.07558.82 1:STN:280:DC%2BD2Mrhtl2gsQ%3D%3D (Pubitemid 41362117)
9. H Poppert O Wolf M Resch, et al. 2004 Differences in number, size and location of intracranial microembolic lesions after surgical versus endovascular treatment without protection device of carotid artery stenosis J Neurol 251 1198 1203 10.1007/s00415-004-0502-4 15503097 10.1007/s00415-004-0502-4 (Pubitemid 39517921)
10. A Petzold G Keir AJ Green, et al. 2003 A specific ELISA for measuring neurofilament heavy chain phosphoforms J Immunol Methods 278 179 190 10.1016/S0022-1759(03)00189-3 12957406 10.1016/S0022-1759(03)00189-3 1:CAS:528:DC%2BD3sXmvVOhtrs%3D (Pubitemid 37281201)
11. W Whiteley MC Tseng P Sandercock 2008 Blood biomarkers in the diagnosis of ischemic stroke: a systematic review Stroke 39 2902 2909 10.1161/STROKEAHA. 107.511261 18658039 10.1161/STROKEAHA.107.511261
12. A Petzold D Gveric M Groves, et al. 2008 Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology Exp Neurol 213 326 335 10.1016/j.expneurol.2008.06.008 18619438 10.1016/j.expneurol. 2008.06.008 1:CAS:528:DC%2BD1cXhtFamsrjE
13. S Engelter S Wetzel LH Bonati, et al. 2008 The clinical significance of diffusion-weighted imaging in stroke and TIA patients Swiss Med Wkly 138 729 740 19130326
14. O Wolf P Heider M Heinz, et al. 2004 Frequency, clinical significance and course of cerebral ischemic events after carotid endarterectomy evaluated by serial diffusion weighted imaging Eur J Vasc Endovasc Surg 27 167 171 10.1016/j.ejvs.2003.11.002 14718899 10.1016/j.ejvs.2003.11.002 1:STN:280:DC%2BD2c%2FitFShsw%3D%3D (Pubitemid 38111684)
15. K Chida K Ogasawara Y Suga, et al. 2009 Postoperative cortical neural loss associated with cerebral hyperperfusion and cognitive impairment after carotid endarterectomy: 123I-iomazenil SPECT study Stroke 40 448 453 10.1161/STROKEAHA.108.515775 19074482 10.1161/STROKEAHA.108.515775
16. L Soinne J Helenius I Tikkala, et al. 2009 The effect of severe carotid occlusive disease and its surgical treatment on cognitive functions of the brain Brain Cogn 69 353 359 10.1016/j.bandc.2008.08.010 18823689 10.1016/j.bandc. 2008.08.010
17. J Unden K Strandberg J Malm, et al. 2009 Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation J Neurol 256 72 77 10.1007/s00415-009-0054-8 19221847 10.1007/s00415-009-0054-8 1:CAS:528:DC%2BD1MXisl2qsr0%3D
18. A Petzold D Baker G Pryce, et al. 2003 Quantification of neurodegeneration by measurement of brain-specific proteins J Neuroimmunol 138 45 48 10.1016/S0165-5728(03)00092-4 12742652 10.1016/S0165-5728(03)00092-4 1:CAS:528:DC%2BD3sXjs1agtb0%3D (Pubitemid 36566417)
19. A Petzold P Michel M Stock, et al. 2008 Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome J Stroke Cerebrovasc Dis 17 196 203 10.1016/j.jstrokecerebrovasdis.2008.02.002 18589339 10.1016/j.jstrokecerebrovasdis.2008.02.002 (Pubitemid 351853439)
20. W Jordan J Hagedohm J Wiltfang, et al. 2002 Biochemical markers of cerebrovascular injury in sleep apnoea syndrome Eur Respir J 20 158 164 10.1183/09031936.02.00862001 12166564 10.1183/09031936.02.00862001 1:STN:280:DC%2BD38vht1KqsA%3D%3D (Pubitemid 34822938)
21. J Sellner P Leyssen S Heiland, et al. 2004 In vivo monitoring of acute flavivirus (Modoc) encephalitis with regional and whole-brain quantitative diffusion magnetic resonance imaging J Neurovirol 10 255 259 10.1080/13550280490463479 15371156 10.1080/13550280490463479 (Pubitemid 39136621)
22. RK Kosior CJ Wright JC Kosior, et al. 2007 3-Tesla versus 1.5-Tesla magnetic resonance diffusion and perfusion imaging in hyperacute ischemic stroke Cerebrovasc Dis 24 361 368 10.1159/000106983 17690549 10.1159/000106983 (Pubitemid 47482042)